Found: 4
Select item for more details and to access through your institution.
Decitabine and vorinostat with FLAG chemotherapy in pediatric relapsed/refractory AML: Report from the therapeutic advances in childhood leukemia and lymphoma (TACL) consortium.
- Published in:
- American Journal of Hematology, 2022, v. 97, n. 5, p. 613, doi. 10.1002/ajh.26510
- By:
- Publication type:
- Article
Real‐world experience in treating pediatric relapsed/refractory or therapy‐related myeloid malignancies with decitabine, vorinostat, and FLAG therapy based on a phase 1 study run by the TACL consortium.
- Published in:
- Pediatric Blood & Cancer, 2022, v. 69, n. 10, p. 1, doi. 10.1002/pbc.29812
- By:
- Publication type:
- Article
Characterizing Pharmacogenetic Testing Among Children's Hospitals.
- Published in:
- CTS: Clinical & Translational Science, 2021, v. 14, n. 2, p. 692, doi. 10.1111/cts.12931
- By:
- Publication type:
- Article
Ocular hemorrhage secondary to thioguanine‐associated veno‐occlusive disease in a child with acute lymphoblastic leukemia in delayed intensification.
- Published in:
- Pediatric Transplantation, 2020, v. 24, n. 1, p. N.PAG, doi. 10.1111/petr.13638
- By:
- Publication type:
- Article